home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Merrimack Pharmaceuticals, Inc. - Common Stock (NQ:MACK)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, May 17, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Merrimack Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 Next >

MACK Stock Earnings: Merrimack Pharmaceuticals Reported Results for Q1 2024 ↗

May 16, 2024

Merrimack Pharmaceuticals just reported results for the first quarter of 2024.

Via InvestorPlace

Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock

May 10, 2024

From Merrimack Pharmaceuticals, Inc.

Via Business Wire

Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt of Stockholder Approval of Plan of Dissolution

May 09, 2024

From Merrimack Pharmaceuticals, Inc.

Via Business Wire

Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution

April 30, 2024

From Merrimack Pharmaceuticals, Inc.

Via Business Wire

Merrimack Receives $225 Million Milestone Payment from Ipsen

March 27, 2024

From Merrimack Pharmaceuticals, Inc.

Via Business Wire

Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) Highlighted for Surprising Price Action

March 25, 2024

Via Investor Brand Network

MACK Stock Earnings: Merrimack Pharmaceuticals Reported Results for Q4 2023 ↗

March 08, 2024

Merrimack Pharmaceuticals just reported results for the fourth quarter of 2023.

Via InvestorPlace

Merrimack Reports Full Year 2023 Financial Results

March 07, 2024

From Merrimack Pharmaceuticals, Inc.

Via Business Wire

Merrimack Reports Ipsen Announcement of Approval By The US FDA of Onivyde® (Irinotecan Liposome Injection) Plus 5 Fluorouracil/Leucovorin and Oxaliplatin (NALIRIFOX) as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

February 13, 2024

From Merrimack Pharmaceuticals, Inc.

Via Business Wire

$2M Bet On Ford? Check Out These 4 Stocks Insiders Are Buying ↗

December 12, 2023

Although U.S. stocks closed higher on Monday, there were a few notable insider trades.

Via Benzinga

Merrimack Reports Third Quarter 2023 Financial Results

November 02, 2023

From Merrimack Pharmaceuticals, Inc.

Via Business Wire

Pancreatic Cancer Battle Boosted by $200M VC Firm

September 19, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:MACK),(NASDAQ:INCY),(NASDAQ:MRTX),(NASDAQ:BNTX) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Death

Merrimack Reports Second Quarter 2023 Financial Results

August 03, 2023

From Merrimack Pharmaceuticals, Inc.

Via Business Wire

Merrimack Reports First Quarter 2023 Financial Results

May 04, 2023

From Merrimack Pharmaceuticals, Inc.

Via Business Wire

Why Jounce Therapeutics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket ↗

March 15, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

March 15, 2023

We're beginning the day with a look at the biggest pre-market stock movers traders need to know about for Wednesday morning!

Via InvestorPlace

Luna Innovations, Guess? And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 15, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Merrimack Reports Full Year 2022 Financial Results

March 09, 2023

From Merrimack Pharmaceuticals, Inc.

Via Business Wire

3 Stocks Insiders Are Buying: Triumph Financial And More ↗

February 01, 2023

Although US stocks closed higher on Tuesday, there were a few notable insider trades.

Via Benzinga

$2.6M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying ↗

January 18, 2023

Although US stocks closed mostly lower on Tuesday, there were a few notable insider trades.

Via Benzinga

Insiders Buying Heska, B. Riley Financial And 2 Other Stocks ↗

January 10, 2023

Although US stocks closed mixed on Monday, there were a few notable insider trades.

Via Benzinga

$1.4 Million Bet On Joint Corp? Check Out These 3 Stocks Insiders Are Buying ↗

January 04, 2023

Although US stocks closed lower on Tuesday, there were a few notable insider trades.

Via Benzinga

Merrimack Pharmaceuticals Extends Section 382 Net Operating Loss Rights Plan

December 05, 2022

From Merrimack Pharmaceuticals, Inc.

Via Business Wire

Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer

November 15, 2022

FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 15, 2022 – USA News Group – Roughly five years after selling its flagship cancer asset Onivyde from to French biotech...

Via FinancialNewsMedia

Topics Death

Biotechs with Evolving Therapies Have Potential to Revolutionize Treatments for Pancreatic Cancer

November 10, 2022

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:MACK),(NASDAQ:NRBO),(NYSE:MRK),(NASDAQ:RNAZ), EQNX::TICKER_END

Via FinancialNewsMedia

Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday ↗

November 10, 2022

Gainers

Via Benzinga

Nasdaq Drops 200 Points; Meta Platforms Shares Jump ↗

November 09, 2022

U.S. stocks traded lower toward the end of trading , with the Nasdaq Composite dropping 200 points on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 09, 2022

Gainers

Via Benzinga

Crude Oil Down Over 2%; Outset Medical Shares Spike Higher ↗

November 09, 2022

U.S. stocks traded lower midway through trading as investors focused on the outcome of the midterm elections.

Via Benzinga

Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session ↗

November 09, 2022

Gainers

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com